HIV-AIDS Antiretroviral Therapy (ART) Portfolio by TAJ PHARMA

Comprehensive HIV Treatment Solutions with Advanced Antiretroviral Therapy

The global fight against Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) continues to rely on the availability of effective, affordable, and high-quality Antiretroviral Therapy (ART) medicines. At TAJ PHARMA, we are committed to supporting healthcare systems, government procurement agencies, international organizations, hospitals, NGOs, and pharmaceutical distributors with a comprehensive portfolio of HIV/AIDS treatment products manufactured according to stringent international quality standards.

Our extensive range of antiretroviral medicines includes Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Integrase Strand Transfer Inhibitors (INSTIs), pediatric formulations, fixed-dose combinations (FDCs), and advanced triple-drug therapies designed to support modern HIV treatment guidelines.

Product NameBrand NameTherapeutic CategoryDosage FormAvailable StrengthsBCS Class (Estimate)
NevirapineNEVITAJAntiretroviral (NNRTI)Oral Suspension10 mg/ml (100 ml)Class II
Lamivudine + ZidovudineLAMIZIDTAJAntiretroviral (NRTI Combination)Tablet150 mg + 300 mgClass III
Abacavir + LamivudineABALAMTAJAntiretroviral (NRTI Combination)Tablet120 mg + 60 mgClass III
Lopinavir + RitonavirLOPIRITAJAntiretroviral (Protease Inhibitor Combination)Tablet200 mg + 50 mgClass IV
Tenofovir + EmtricitabineTENEMTAJAntiretroviral (NRTI Combination)Tablet300 mg + 200 mgClass III
Tenofovir Alafenamide + Emtricitabine + DolutegravirTAFEMDOLTAJAntiretroviral Triple CombinationTablet25 mg + 200 mg + 50 mgClass II
DolutegravirDOLUTAJIntegrase Inhibitor (INSTI)Tablet50 mgClass II
Dolutegravir + Lamivudine + TenofovirDOLLAMTENTAJAntiretroviral Triple CombinationTablet50 mg + 300 mg + 300 mgClass II
ZidovudineZIDOTAJAntiretroviral (NRTI)Oral Syrup50 mg/5 mlClass I
LamivudineLAMITAJAntiretroviral (NRTI)Oral Syrup50 mg/5 mlClass III
LamivudineLAMITAJAntiretroviral (NRTI)Tablet150 mgClass III
Abacavir + Lamivudine + DolutegravirABALAMDOLTAJAntiretroviral Triple CombinationDispersible Tablet60 mg + 30 mg + 5 mgClass III
Abacavir + LamivudineABALAMTAJAntiretroviral (NRTI Combination)Tablet600 mg + 300 mgClass III
RaltegravirRALTEGTAJIntegrase Inhibitor (INSTI)Chewable Tablet100 mgClass II
RitonavirRITOTAJProtease Inhibitor BoosterCapsule/Tablet100 mgClass IV
Lamivudine + Tenofovir + EfavirenzLAMTENEFTAJAntiretroviral Triple CombinationTablet300 mg + 300 mg + 400 mgClass II
TenofovirTENOTAJAntiretroviral (NRTI)Tablet300 mgClass III
Lamivudine + ZidovudineLAMIZIDTAJ DTAntiretroviral CombinationDispersible Tablet30 mg + 60 mgClass III
AbacavirABATAJAntiretroviral (NRTI)Tablet300 mgClass III
DolutegravirDOLUTAJ JuniorIntegrase Inhibitor (INSTI)Tablet10 mgClass II
Darunavir + RitonavirDARURITAJProtease Inhibitor CombinationTablet400 mg + 50 mgClass IV
Darunavir + RitonavirDARURITAJProtease Inhibitor CombinationTablet600 mg + 100 mgClass IV
Darunavir + RitonavirDARURITAJProtease Inhibitor CombinationTablet800 mg + 100 mgClass IV

Why Antiretroviral Therapy (ART) is Essential in HIV Management

Antiretroviral Therapy has transformed HIV infection from a life-threatening disease into a manageable chronic condition. Modern ART regimens suppress viral replication, restore immune function, reduce opportunistic infections, and significantly improve patient survival rates.

The primary objectives of HIV treatment include:

  • Achieving viral suppression
  • Maintaining immune system function
  • Preventing HIV transmission
  • Improving quality of life
  • Reducing HIV-related morbidity and mortality
  • Supporting long-term treatment adherence

The evolution of HIV treatment has led to highly effective single-tablet regimens and fixed-dose combinations that simplify therapy while improving patient compliance.


TAJ PHARMA HIV/AIDS Antiretroviral Product Portfolio

Our ART portfolio covers a broad range of treatment options suitable for adults, adolescents, and pediatric patients.

NNRTI-Based Antiretroviral Products

NEVITAJ (Nevirapine Oral Suspension)

Nevirapine remains an important NNRTI used in HIV treatment programs, particularly in pediatric populations. NEVITAJ Oral Suspension provides flexible dosing and improved administration for children requiring antiretroviral treatment.

Strength Available:

  • 10 mg/ml Oral Suspension (100 ml)

Benefits

  • Pediatric-friendly formulation
  • Easy administration
  • Proven antiviral efficacy
  • Suitable for weight-based dosing

NRTI-Based Antiretroviral Products

LAMITAJ (Lamivudine)

Lamivudine is a cornerstone NRTI utilized in numerous HIV treatment regimens worldwide.

Available Strengths:

  • Lamivudine 150 mg Tablets
  • Lamivudine 50 mg/5 ml Oral Syrup

Key Advantages

  • Excellent safety profile
  • Broad inclusion in WHO-recommended regimens
  • Suitable for adults and pediatric patients

TENOTAJ (Tenofovir Disoproxil Fumarate)

Tenofovir remains one of the most widely prescribed antiretroviral medicines globally.

Available Strength:

  • Tenofovir 300 mg Tablets

Clinical Benefits

  • Strong antiviral activity
  • High barrier to resistance
  • Long-term treatment suitability

ABATAJ (Abacavir)

Abacavir is an important NRTI frequently used in first-line and pediatric HIV treatment programs.

Available Strength:

  • Abacavir 300 mg Tablets

Applications

  • Combination HIV therapy
  • Pediatric treatment regimens
  • Alternative backbone therapy

ZIDOTAJ (Zidovudine Oral Syrup)

Zidovudine remains a recognized component in HIV management and prevention strategies.

Available Strength:

  • Zidovudine 50 mg/5 ml Oral Syrup

Advantages

  • Pediatric suitability
  • Established clinical history
  • Reliable antiviral activity

Fixed-Dose Combination Antiretroviral Products

Fixed-dose combinations improve adherence by reducing pill burden and simplifying treatment schedules.

LAMIZIDTAJ

Lamivudine 150 mg + Zidovudine 300 mg Tablets

This dual-NRTI combination provides an established backbone therapy used in various HIV treatment programs.

Key Benefits

  • Reduced tablet count
  • Improved compliance
  • Proven clinical effectiveness

ABALAMTAJ

Abacavir 120 mg + Lamivudine 60 mg Tablets

Abacavir 600 mg + Lamivudine 300 mg Tablets

ABALAMTAJ offers flexible dosing options suitable for pediatric and adult HIV patients.

Advantages

  • Convenient fixed-dose therapy
  • Simplified treatment administration
  • Enhanced patient adherence

TENEMTAJ

Tenofovir 300 mg + Emtricitabine 200 mg Tablets

This globally recognized combination forms a foundation for many first-line HIV treatment regimens.

Benefits

  • Potent antiviral activity
  • Once-daily dosing potential
  • Excellent treatment adherence support

Integrase Inhibitor-Based HIV Medicines

Integrase inhibitors have become the preferred treatment option in many modern HIV guidelines due to their efficacy and tolerability.

DOLUTAJ (Dolutegravir)

Available Strengths

  • Dolutegravir 50 mg Tablets
  • Dolutegravir 10 mg Tablets (DOLUTAJ Junior)

Key Features

  • Rapid viral suppression
  • High resistance barrier
  • Preferred first-line therapy component
  • Suitable for diverse patient populations

RALTEGTAJ (Raltegravir)

Available Strength

  • Raltegravir 100 mg Chewable Tablets

Advantages

  • Pediatric-friendly administration
  • Proven integrase inhibition
  • Effective viral suppression

Advanced Triple Antiretroviral Combinations

Modern HIV treatment increasingly relies on potent triple-drug combinations.

DOLLAMTENTAJ

Dolutegravir 50 mg + Lamivudine 300 mg + Tenofovir 300 mg Tablets

This fixed-dose combination supports simplified HIV treatment protocols and excellent treatment outcomes.

Clinical Advantages

  • Once-daily therapy potential
  • Reduced pill burden
  • Strong virologic suppression

TAFEMDOLTAJ

Tenofovir Alafenamide 25 mg + Emtricitabine 200 mg + Dolutegravir 50 mg Tablets

An advanced antiretroviral formulation combining potent efficacy with improved treatment convenience.

Benefits

  • Modern HIV treatment option
  • Enhanced tolerability profile
  • Comprehensive antiviral coverage

LAMTENEFTAJ

Lamivudine 300 mg + Tenofovir 300 mg + Efavirenz 400 mg Tablets

A well-established triple-drug regimen utilized across multiple HIV treatment programs.

Advantages

  • Widely recognized combination
  • Proven effectiveness
  • Simplified dosing regimen

ABALAMDOLTAJ

Abacavir 60 mg + Lamivudine 30 mg + Dolutegravir 5 mg Dispersible Tablets

Designed specifically for pediatric HIV patients requiring age-appropriate formulations.

Benefits

  • Child-friendly dispersible dosage form
  • Accurate dosing flexibility
  • Enhanced adherence in pediatric populations

Protease Inhibitor-Based HIV Therapies

Protease inhibitors remain critical options for second-line and specialized HIV treatment strategies.

LOPIRITAJ

Lopinavir 200 mg + Ritonavir 50 mg Tablets

Clinical Benefits

  • Effective viral suppression
  • Established treatment history
  • Suitable for multiple treatment settings

RITOTAJ

Ritonavir 100 mg Capsules/Tablets

Ritonavir serves both as an antiretroviral agent and pharmacokinetic enhancer for protease inhibitor-based regimens.

Advantages

  • Drug boosting capabilities
  • Improved treatment effectiveness
  • Broad clinical utilization

DARURITAJ

Available Strengths

  • Darunavir 400 mg + Ritonavir 50 mg Tablets
  • Darunavir 600 mg + Ritonavir 100 mg Tablets
  • Darunavir 800 mg + Ritonavir 100 mg Tablets

Key Benefits

  • High efficacy in treatment-experienced patients
  • Strong resistance profile
  • Flexible dosing options

Pediatric HIV Treatment Solutions

Children living with HIV require specialized dosage forms that facilitate accurate dosing and treatment adherence.

TAJ PHARMA offers pediatric-focused formulations including:

  • NEVITAJ Oral Suspension
  • LAMITAJ Oral Syrup
  • ZIDOTAJ Oral Syrup
  • ABALAMDOLTAJ Dispersible Tablets
  • LAMIZIDTAJ DT Dispersible Tablets
  • DOLUTAJ Junior Tablets
  • RALTEGTAJ Chewable Tablets

These formulations support healthcare providers in delivering effective treatment across various pediatric age groups.


Quality Manufacturing Standards at TAJ PHARMA

Quality remains the foundation of every TAJ PHARMA product. Our manufacturing operations are supported by internationally recognized systems designed to ensure product safety, efficacy, consistency, and regulatory compliance.

Our facilities operate under rigorous quality frameworks including:

  • WHO-GMP Standards
  • PIC/S Compliance
  • ISO Quality Systems
  • GLP Compliance
  • International Regulatory Documentation Support
  • Comprehensive Stability Programs
  • Robust Pharmacovigilance Practices

Each antiretroviral product undergoes stringent quality control and quality assurance procedures to ensure reliable therapeutic performance.


Global Supply Capabilities for HIV/AIDS Programs

TAJ PHARMA supports:

  • Government Tender Supplies
  • Ministry of Health Procurement Programs
  • International HIV Treatment Initiatives
  • NGO Healthcare Programs
  • Hospital Procurement Networks
  • Private Healthcare Markets
  • Pharmaceutical Distributors
  • Humanitarian Healthcare Projects

Our comprehensive ART portfolio enables healthcare providers worldwide to access dependable treatment solutions for HIV-positive patients.

The TAJ PHARMA HIV/AIDS Antiretroviral Therapy portfolio represents a comprehensive range of modern HIV treatment solutions, including NRTIs, NNRTIs, Integrase Inhibitors, Protease Inhibitors, pediatric formulations, and advanced fixed-dose combinations. Through quality-driven manufacturing, regulatory excellence, and a commitment to global healthcare access, we continue to support HIV treatment programs with effective, affordable, and reliable antiretroviral medicines that contribute to improved patient outcomes worldwide.